These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6582679)

  • 1. Characterization and treatment of the non-lymphoblastic crisis of chronic myelogenous leukemia.
    Mariani G; Annino L; Solinas S; Mandelli F
    Tumori; 1983 Dec; 69(6):521-6. PubMed ID: 6582679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
    Lemoine F; Najman A; Laporte JP; Gorin NC; Duhamel G
    Cancer Treat Rep; 1985 Feb; 69(2):203-4. PubMed ID: 3855698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Philadelphia-chromosome-positive pre-B-cell leukemia presenting as blast crisis of chronic myelogenous leukemia.
    Vogler LB; Crist WM; Vinson PC; Sarrif A; Brattain MG; Coleman MS
    Blood; 1979 Nov; 54(5):1164-70. PubMed ID: 315245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive combination chemotherapy (ROAP 10) and splenectomy in the management of chronic myelogenous leukemia.
    Kantarjian HM; Vellekoop L; McCredie KB; Keating MJ; Hester J; Smith T; Barlogie B; Trujillo J; Freireich EJ
    J Clin Oncol; 1985 Feb; 3(2):192-200. PubMed ID: 3855444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of the lymphoid blast crisis of chronic myeloid leukemia.
    Bassan R; Battista R; Comotti B; Minetti B; Chisesi T; Dini E; Barbui T
    Eur J Cancer Clin Oncol; 1987 May; 23(5):513-5. PubMed ID: 3477457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
    Lauten M; Möricke A; Beier R; Zimmermann M; Stanulla M; Meissner B; Odenwald E; Attarbaschi A; Niemeyer C; Niggli F; Riehm H; Schrappe M
    Haematologica; 2012 Jul; 97(7):1048-56. PubMed ID: 22271901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.
    Koller CA; Miller DM
    N Engl J Med; 1986 Dec; 315(23):1433-8. PubMed ID: 2431313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxyurea and 6-mercaptopurine in the treatment of chronic granulocytic leukemia.
    Lazzarino M; Morra E; Brusamolino E; Inverardi D; Castelli G; Merante S; Bernasconi C
    Am J Clin Oncol; 1986 Feb; 9(1):45-9. PubMed ID: 3513537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival.
    Kantarjian HM; Smith TL; McCredie KB; Keating MJ; Walters RS; Talpaz M; Hester JP; Bligham G; Gehan E; Freireich EJ
    Blood; 1985 Dec; 66(6):1326-35. PubMed ID: 3864497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy of the blast phase of chronic granulocytic leukemia with mithramycin and hydroxyurea.
    Queisser W; Herrmann F; Lindemann A; Anger B; Hiddemann W; Krey U
    Onkologie; 1988 Jun; 11(3):145-6. PubMed ID: 2970612
    [No Abstract]   [Full Text] [Related]  

  • 11. Mitoxantrone, vincristine, and prednisone in adults with relapsed or primarily refractory acute lymphocytic leukemia and terminal deoxynucleotidyl transferase positive blastic phase chronic myelocytic leukemia.
    Paciucci PA; Keaveney C; Cuttner J; Holland JF
    Cancer Res; 1987 Oct; 47(19):5234-7. PubMed ID: 3476201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and prognostic features of Philadelphia chromosome-negative chronic myelogenous leukemia.
    Kantarjian HM; Keating MJ; Walters RS; McCredie KB; Smith TL; Talpaz M; Beran M; Cork A; Trujillo JM; Freireich EJ
    Cancer; 1986 Nov; 58(9):2023-30. PubMed ID: 3463397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of elderly patients with acute myelogenous leukemia: analysis of 126 AML cases.
    Iwakiri R; Ohta M; Mikoshiba M; Tsutsumi H; Kumakawa T; Mori M
    Int J Hematol; 2002 Jan; 75(1):45-50. PubMed ID: 11843290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitoxantrone as a single agent and in combination chemotherapy in patients with refractory acute leukemia.
    Paciucci PA; Cuttner J; Holland JF
    Semin Oncol; 1984 Sep; 11(3 Suppl 1):36-40. PubMed ID: 6385264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical investigation of human alpha interferon in chronic myelogenous leukemia.
    Talpaz M; Kantarjian HM; McCredie KB; Keating MJ; Trujillo J; Gutterman J
    Blood; 1987 May; 69(5):1280-8. PubMed ID: 3471281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response of chronic myelogenous leukemia patients to COAP-splenectomy. A Southwest Oncology Group study.
    Hester JP; Waddell CC; Coltman CA; Morrison FS; Stephens RL; Balcerzak SP; Baker LH; Chen TT
    Cancer; 1984 Nov; 54(9):1977-82. PubMed ID: 6592034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous marrow transplantation for patients with chronic myelogenous leukemia (CML) in blast crisis.
    Thomas MR; Robinson WA; Dantas M; Koeppler H; Drebing C; Glode LM
    Am J Hematol; 1984 Feb; 16(2):105-12. PubMed ID: 6364801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of myeloid blastic crisis of chronic myelogenous leukemia.
    Preisler HD; Raza A; Higby D; Kirshner J; Woll J; Bennett J; Winton L; Weiner R; Richman C; Golomb H
    Cancer Treat Rep; 1984 Nov; 68(11):1351-5. PubMed ID: 6388833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.
    Inhorn RC; Aster JC; Roach SA; Slapak CA; Soiffer R; Tantravahi R; Stone RM
    Blood; 1995 Apr; 85(7):1881-7. PubMed ID: 7661940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of day 14 blast percentage and the absolute blast index in bone marrow of children with acute lymphoblastic leukemia.
    Visser JH; Wessels G; Hesseling PB; Louw I; Oberholster E; Mansvelt EP
    Pediatr Hematol Oncol; 2001; 18(3):187-91. PubMed ID: 11293286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.